Henry Chambers, III, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave, #3419
San Francisco CA 94110
Phone628-206-5437
vCardDownload vCard
    Other Positions
    Title(s)Chief, Division of Infectious Diseases, SFGH

    Title(s)Director, Clinical Research Services, CTSI


    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine
    Vanderbilt UniversityM.D.School of Medicine
    Centre College Kentucky B.A.

    Collapse Overview 
    Collapse Overview
    Dr. Chambers clinical and research interests are antimicrobial drug resistance, staphylococcal infections, experimental therapeutics, and epidemiology and pathogenesis of disease caused by Staphylococcus aureus. He is editor for the Sanford Guide to Antimicrobial Therapy and he has over 200 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases.

    Dr. Chambers received his BA from Centre College in Kentucky and is a graduate of the Vanderbilt University School of Medicine. He trained in Internal Medicine and Infectious Diseases at the University of California San Francisco. Dr. Chambers has been a member of the medical faculty of the UCSF since 1983 where he currently is Professor of Medicine, Medical Director of Clinical Research Services for CTSI. He is an editor for Antimicrobial Agents and Chemotherapy, a reviewer for numerous medical publications, a peer reviewer for NIH study sections.

    Collapse Research 
    Collapse Research Activities and Funding
    Antibacterial Resistance Leadership Group (ARLG)
    NIH UM1AI104681Jun 1, 2013 - Nov 30, 2026
    Role: Co-Principal Investigator
    Novel Mechanisms of Beta-lactam Resistance in Staph Aureus
    NIH R01AI100291Aug 1, 2012 - Dec 31, 2022
    Role: Principal Investigator
    Novel Mechanisms of Beta-lactam Resistance in Staph Aureus
    NIH R56AI100291Aug 1, 2012 - Dec 31, 2017
    Role: Principal Investigator
    Genetic Basis of Virulence of Community MRSA Clone USA300
    NIH R01AI070289Apr 1, 2008 - Mar 31, 2012
    Role: Principal Investigator
    Gordon Research Conference on Staphylococcal Diseases
    NIH R13AI050556Jul 1, 2001 - Jun 30, 2002
    Role: Principal Investigator
    Biology of Infectious Diseases Training Program
    NIH T32AI007641Aug 1, 2000 - Aug 31, 2022
    Role: Principal Investigator
    PENICILLIN INTERACTIVE PROTEINS OF STAPHYLOCOCCUS AUREUS
    NIH R01AI046610Feb 1, 2000 - Jan 31, 2005
    Role: Principal Investigator
    GORDON CONFERENCE ON STAPHYLOCOCCAL DISEASES
    NIH R13AI043943May 1, 1999 - Apr 30, 2000
    Role: Principal Investigator
    VANCOMYCIN-RESISTANT STAPHYLOCOCCUS AUREUS
    NIH R03AI043959Apr 1, 1999 - Mar 31, 2002
    Role: Principal Investigator
    PENICILLIN BINDING PROTEINS OF STAPHYLOCOCCUS AUREUS
    NIH R21AI032496Sep 30, 1996 - Sep 29, 1999
    Role: Principal Investigator
    DEVELOPMENT OF DRUGS FOR TREATING TUBERCULOSIS
    NIH R01AI033702Sep 30, 1992 - Aug 31, 1997
    Role: Principal Investigator
    METHICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS
    NIH R29AI027406Dec 1, 1988 - Nov 30, 1993
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The positioning of ceftobiprole in the treatment of Staphylococcus aureus bacteremia. Clin Infect Dis. 2024 Mar 11. Minter DJ, Appa A, Chambers HF, Doernberg SB. PMID: 38466317.
      View in: PubMed   Mentions:    Fields:    
    2. Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. Clin Infect Dis. 2024 02 17; 78(2):259-268. Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Leister-Tebbe H, Hill C, Geres H, Holland TL, Doernberg SB, Chambers HF, Fowler VG, Evans SR, Boucher HW, Antibacterial Resistance Leadership Group. PMID: 37740559; PMCID: PMC10874265.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Sensitizing methicillin-resistant Staphylococcus aureus (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidine. Antimicrob Agents Chemother. 2024 Feb 13; e0162723. Ersoy SC, Proctor RA, Rose WE, Abdelhady W, Fan S-H, Madrigal SL, Elsayed AM, Chambers HF, Sobral RG, Bayer AS. PMID: 38349162.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Duke Infective Endocarditis Criteria 3.0 for the Clinician: Defining What Is Possible. Clin Infect Dis. 2024 Feb 08. Chambers HF, Zhang S, Evans S. PMID: 38330224.
      View in: PubMed   Mentions:    Fields:    
    5. In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0125823. Iovleva A, McElheny CL, Fowler EL, Cober E, Herc ES, Arias CA, Hill C, Baum K, Fowler VG, Chambers HF, Greenwood-Quaintance KE, Patel R, van Duin D, Bonomo RA, Doi Y. PMID: 38289078; PMCID: PMC10916374.
      View in: PubMed   Mentions:    Fields:    
    6. Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice. Clin Infect Dis. 2023 11 30; 77(11):1489-1491. Minter DJ, Appa A, Chambers HF, Doernberg SB. PMID: 38031168.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    7. Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice. Clin Infect Dis. 2023 11 30; 77(11):e57-e68. Minter DJ, Appa A, Chambers HF, Doernberg SB. PMID: 37950887.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in Staphylococcus aureus. bioRxiv. 2023 Oct 27. Lai LY, Satishkumar N, Cardozo S, Hemmadi V, Marques LB, Huang L, Filipe SR, Pinho MG, Chambers HF, Chatterjee SS. PMID: 37961375; PMCID: PMC10634853.
      View in: PubMed   Mentions:
    9. Spatial clusters of extended-spectrum beta-lactamase-producing Escherichia coli causing community-onset bacteriuria due to repeat infections: cluster analysis from a large urban medical center, San Francisco, 2014-2020. Antimicrob Resist Infect Control. 2023 10 20; 12(1):115. Raphael E, Inamdar PP, Belmont C, Shariff-Marco S, Huang AJ, Chambers HF. PMID: 37858209; PMCID: PMC10588154.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions. Clin Infect Dis. 2023 10 16; 77(Suppl 4):S279-S287. Chambers HF, Cross HR, Souli M, Evans SR, Patel R, Fowler VG, Antibacterial Resistance Leadership Group. PMID: 37843121; PMCID: PMC10578046.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Role of the NaHCO3 Transporter MpsABC in the NaHCO3-β-Lactam-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureus. Microbiol Spectr. 2023 06 15; 11(3):e0014123. Fan SH, Proctor RA, Ersoy SC, Manna AC, Cheung AL, Götz F, Chambers HF, Bayer AS. PMID: 37102972; PMCID: PMC10269494.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    12. Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials. Clin Infect Dis. 2023 02 08; 76(3):e1157-e1165. Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Hill C, Gelone SP, Mariano D, Baba T, Holland TL, Doernberg SB, Chambers HF, Fowler VG, Evans SR, Boucher HW. PMID: 36031403; PMCID: PMC10169394.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    13. Structural basis of broad-spectrum β-lactam resistance in Staphylococcus aureus. Nature. 2023 01; 613(7943):375-382. Alexander JAN, Worrall LJ, Hu J, Vuckovic M, Satishkumar N, Poon R, Sobhanifar S, Rosell FI, Jenkins J, Chiang D, Mosimann WA, Chambers HF, Paetzel M, Chatterjee SS, Strynadka NCJ. PMID: 36599987; PMCID: PMC9834060.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    14. Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers. Antimicrob Agents Chemother. 2022 12 20; 66(12):e0093522. Lodise TP, O'Donnell JN, Raja S, Guptill JT, Zaharoff S, Schwager N, Fowler VG, Beresnev T, Wall A, Wiegand K, Serti Chrisos E, Balevic S, Chambers HF, Antibacterial Resistance Leadership Group. PMID: 36394316; PMCID: PMC9764989.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    15. Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults. Antimicrob Agents Chemother. 2022 12 20; 66(12):e0093622. Lodise TP, O'Donnell JN, Balevic S, Liu X, Gu K, George J, Raja S, Guptill JT, Zaharoff S, Schwager N, Fowler VG, Wall A, Wiegand K, Chambers HF, Antibacterial Resistance Leadership Group. PMID: 36394326; PMCID: PMC9764983.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    16. Influence of Sodium Bicarbonate on Wall Teichoic Acid Synthesis and β-Lactam Sensitization in NaHCO3-Responsive and Nonresponsive Methicillin-Resistant Staphylococcus aureus. Microbiol Spectr. 2022 12 21; 10(6):e0342222. Ersoy SC, Gonçalves B, Cavaco G, Manna AC, Sobral RG, Nast CC, Proctor RA, Chambers HF, Cheung A, Bayer AS. PMID: 36377886; PMCID: PMC9769754.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    17. Confronting antimicrobial resistance together. Am J Physiol Lung Cell Mol Physiol. 2022 11 01; 323(5):L643-L645. Chambers HF, Fowler VG, Antibacterial Resistance Leadership Group. PMID: 36193938; PMCID: PMC9662793.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. The NaHCO3-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureus (MRSA) Is Influenced by mecA Genotype. Antimicrob Agents Chemother. 2022 06 21; 66(6):e0025222. Ersoy SC, Manna AC, Proctor RA, Chambers HF, Harrison EM, Bayer AS, Cheung A. PMID: 35575577; PMCID: PMC9211399.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    19. A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection. Open Forum Infect Dis. 2022 Jun; 9(6):ofac140. Howard-Anderson J, Dai W, Yahav D, Hamasaki T, Turjeman A, Koppel F, Franceschini E, Hill C, Sund Z, Chambers HF, Fowler VG, Boucher HW, Evans SR, Paul M, Holland TL, Doernberg SB. PMID: 35615299; PMCID: PMC9125302.
      View in: PubMed   Mentions: 1  
    20. Comparative 1-Year Outcomes of Invasive Staphylococcus aureus Infections Among Persons With and Without Drug Use: An Observational Cohort Study. Clin Infect Dis. 2022 01 29; 74(2):263-270. Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin PO, Jain V. PMID: 33904900; PMCID: PMC8800187.
      View in: PubMed   Mentions: 6     Fields:    
    21. Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Open Forum Infect Dis. 2022 Feb; 9(2):ofab651. Lodise TP, Scheetz M, Carreno JJ, Chambers H, Fowler V, Holland TL. PMID: 35079599; PMCID: PMC8783632.
      View in: PubMed   Mentions: 3  
    22. Loss of GdpP Function in Staphylococcus aureus Leads to β-Lactam Tolerance and Enhanced Evolution of β-Lactam Resistance. Antimicrob Agents Chemother. 2022 02 15; 66(2):e0143121. Poon R, Basuino L, Satishkumar N, Chatterjee A, Mukkayyan N, Buggeln E, Huang L, Nair V, Argudín MA, Datta SK, Chambers HF, Chatterjee SS. PMID: 34843389; PMCID: PMC8846394.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    23. Impact of Bicarbonate-β-Lactam Exposures on Methicillin-Resistant Staphylococcus aureus (MRSA) Gene Expression in Bicarbonate-β-Lactam-Responsive vs. Non-Responsive Strains. Genes (Basel). 2021 10 20; 12(11). Ersoy SC, Hanson BM, Proctor RA, Arias CA, Tran TT, Chambers HF, Bayer AS. PMID: 34828256; PMCID: PMC8619011.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    24. Oral versus Intravenous Antibiotics for Endocarditis. N Engl J Med. 2021 09 16; 385(12):1141-1143. Chowdhury J, Patel R, Chambers H. PMID: 34525290.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    25. Patient-Directed Discharges Among Persons Who Use Drugs Hospitalized with Invasive Staphylococcus aureus Infections: Opportunities for Improvement. Am J Med. 2022 01; 135(1):91-96. Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin P, Jain V. PMID: 34508704.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    26. A Combined Phenotypic-Genotypic Predictive Algorithm for In Vitro Detection of Bicarbonate: β-Lactam Sensitization among Methicillin-Resistant Staphylococcus aureus (MRSA). Antibiotics (Basel). 2021 Sep 09; 10(9). Ersoy SC, Rose WE, Patel R, Proctor RA, Chambers HF, Harrison EM, Pak Y, Bayer AS. PMID: 34572671; PMCID: PMC8469475.
      View in: PubMed   Mentions: 7  
    27. Antibacterial Resistance Leadership Group 2.0: Back to Business. Clin Infect Dis. 2021 08 16; 73(4):730-739. Chambers HF, Evans SR, Patel R, Cross HR, Harris AD, Doi Y, Boucher HW, van Duin D, Tsalik EL, Holland TL, Pettigrew MM, Tamma PD, Hodges KR, Souli M, Fowler VG. PMID: 33588438; PMCID: PMC8366825.
      View in: PubMed   Mentions: 7     Fields:    Translation:Cells
    28. Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system. Antimicrob Resist Infect Control. 2021 08 11; 10(1):118. Raphael E, Glymour MM, Chambers HF. PMID: 34380549; PMCID: PMC8359060.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    29. Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-Resistant Staphylococcus aureus (MRSA). Antimicrob Agents Chemother. 2023 05 01; 65(5). Ersoy SC, Chambers HF, Proctor RA, Rosato AE, Mishra NN, Xiong YQ, Bayer AS. PMID: 33649115; PMCID: PMC8092911.
      View in: PubMed   Mentions: 9     Fields:    
    30. Skin and Soft Tissue Infections. Infect Dis Clin North Am. 2021 03; 35(1):xiii-xiv. Chambers HF. PMID: 33494875.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    31. Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity. Lancet Infect Dis. 2021 09; 21(9):e296-e301. Spinelli MA, Glidden DV, Gennatas ED, Bielecki M, Beyrer C, Rutherford G, Chambers H, Goosby E, Gandhi M. PMID: 33631099; PMCID: PMC7906703.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsPHPublic Health
    32. Skin and Soft Tissue Infections in Persons Who Inject Drugs. Infect Dis Clin North Am. 2021 Mar; 35(1):169-181. Chambers HF. PMID: 33303334.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    33. Rifabutin to the Rescue? J Infect Dis. 2020 10 01; 222(9):1422-1424. Chambers HF. PMID: 32914842.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    34. Native-Valve Infective Endocarditis. N Engl J Med. 2020 08 06; 383(6):567-576. Chambers HF, Bayer AS. PMID: 32757525.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    35. Differential Trends in Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections in Four Health Care Facilities in a Single Metropolitan Area: A Retrospective Analysis. Microb Drug Resist. 2021 Feb; 27(2):154-161. Raphael E, Chambers HF. PMID: 32589493.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    36. Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus. J Biol Chem. 2020 08 07; 295(32):10870-10884. Alexander JAN, Radaeva M, King DT, Chambers HF, Cherkasov A, Chatterjee SS, Strynadka NCJ. PMID: 32518158; PMCID: PMC7415986.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    37. Scope and Predictive Genetic/Phenotypic Signatures of Bicarbonate (NaHCO3) Responsiveness and β-Lactam Sensitization in Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2020 04 21; 64(5). Ersoy SC, Otmishi M, Milan VT, Li L, Pak Y, Mediavilla J, Chen L, Kreiswirth B, Chambers HF, Proctor RA, Xiong YQ, Fowler VG, Bayer AS. PMID: 32041719; PMCID: PMC7179597.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    38. The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE). Clin Infect Dis. 2020 04 10; 70(8):1536-1545. Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler VG, Holland TL. PMID: 31157370; PMCID: PMC7145993.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    39. Analytical Evaluation of the Abbott RealTime CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Rectal and Pharyngeal Swabs. J Mol Diagn. 2020 06; 22(6):811-816. Adamson PC, Pandori MW, Doernberg SB, Komarow L, Sund Z, Tran TTT, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JD, Antibacterial Resistance Leadership Group. PMID: 32247863; PMCID: PMC7295135.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    40. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. Lancet Infect Dis. 2020 06; 20(6):731-741. van Duin D, Arias CA, Komarow L, Chen L, Hanson BM, Weston G, Cober E, Garner OB, Jacob JT, Satlin MJ, Fries BC, Garcia-Diaz J, Doi Y, Dhar S, Kaye KS, Earley M, Hujer AM, Hujer KM, Domitrovic TN, Shropshire WC, Dinh A, Manca C, Luterbach CL, Wang M, Paterson DL, Banerjee R, Patel R, Evans S, Hill C, Arias R, Chambers HF, Fowler VG, Kreiswirth BN, Bonomo RA, Multi-Drug Resistant Organism Network Investigators. PMID: 32151332; PMCID: PMC7473597.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCells
    41. Ability of Bicarbonate Supplementation To Sensitize Selected Methicillin-Resistant Staphylococcus aureus Strains to β-Lactam Antibiotics in an Ex Vivo Simulated Endocardial Vegetation Model. Antimicrob Agents Chemother. 2020 02 21; 64(3). Rose WE, Bienvenida AM, Xiong YQ, Chambers HF, Bayer AS, Ersoy SC. PMID: 31844004; PMCID: PMC7038310.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    42. Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia? Antimicrob Agents Chemother. 2019 11; 63(11). Kalil AC, Holubar M, Deresinski S, Chambers HF. PMID: 31640977; PMCID: PMC6811451.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    43. Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics. Antimicrob Agents Chemother. 2019 07; 63(7). Ersoy SC, Abdelhady W, Li L, Chambers HF, Xiong YQ, Bayer AS. PMID: 31010857; PMCID: PMC6591647.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    44. Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection. Clin Infect Dis. 2019 05 02; 68(10):1691-1698. Doernberg SB, Tran TTT, Tong SYC, Paul M, Yahav D, Davis JS, Leibovici L, Boucher HW, Corey GR, Cosgrove SE, Chambers HF, Fowler VG, Evans SR, Holland TL, Antibacterial Resistance Leadership Group. PMID: 30321315; PMCID: PMC6495020.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    45. A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection. Clin Infect Dis. 2019 04 24; 68(9):1502-1511. Guimaraes AO, Cao Y, Hong K, Mayba O, Peck MC, Gutierrez J, Ruffin F, Carrasco-Triguero M, Dinoso JB, Clemenzi-Allen A, Koss CA, Maskarinec SA, Chambers HF, Fowler VG, Baruch A, Rosenberger CM. PMID: 30165412; PMCID: PMC6481998.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    46. Omadacycline - The Newest Tetracycline. N Engl J Med. 2019 02 07; 380(6):588-589. Chambers HF. PMID: 30726683.
      View in: PubMed   Mentions: 12     Fields:    Translation:Cells
    47. Structural and kinetic analyses of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance in Staphylococcus aureus. J Biol Chem. 2018 12 21; 293(51):19854-19865. Alexander JAN, Chatterjee SS, Hamilton SM, Eltis LD, Chambers HF, Strynadka NCJ. PMID: 30366985; PMCID: PMC6314119.
      View in: PubMed   Mentions: 19     Fields:    Translation:Cells
    48. Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. Clin Infect Dis. 2018 09 28; 67(8):1168-1174. Doernberg SB, Abbo LM, Burdette SD, Fishman NO, Goodman EL, Kravitz GR, Leggett JE, Moehring RW, Newland JG, Robinson PA, Spivak ES, Tamma PD, Chambers HF. PMID: 29590355.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    49. PBP4: A New Perspective on Staphylococcus aureus β-Lactam Resistance. Microorganisms. 2018 06 22; 6(3). da Costa TM, de Oliveira CR, Chambers HF, Chatterjee SS. PMID: 29932109; PMCID: PMC6164785.
      View in: PubMed   Mentions: 19  
    50. PBP4 activity and its overexpression are necessary for PBP4-mediated high-level β-lactam resistance. J Antimicrob Chemother. 2018 05 01; 73(5):1177-1180. Basuino L, Jousselin A, Alexander JAN, Strynadka NCJ, Pinho MG, Chambers HF, Chatterjee SS. PMID: 29360990; PMCID: PMC5909641.
      View in: PubMed   Mentions: 10     Fields:    Translation:Cells
    51. Cellulitis and Soft Tissue Infections. Ann Intern Med. 2018 Feb 06; 168(3):ITC17-ITC32. Bystritsky R, Chambers H. PMID: 29404597.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    52. A Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med. 2017 12 28; 377(26):e36. Daum RS, Kumar N, Chambers HF. PMID: 29281570.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and Abscess. Open Forum Infect Dis. 2017; 4(4):ofx232. Bowen AC, Carapetis JR, Currie BJ, Fowler V, Chambers HF, Tong SYC. PMID: 29255730; PMCID: PMC5730933.
      View in: PubMed   Mentions: 17  
    54. Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2017 11; 61(11). Katayama Y, Azechi T, Miyazaki M, Takata T, Sekine M, Matsui H, Hanaki H, Yahara K, Sasano H, Asakura K, Takaku T, Ochiai T, Komatsu N, Chambers HF. PMID: 28827421; PMCID: PMC5655046.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    55. PBP4 Mediates β-Lactam Resistance by Altered Function. Antimicrob Agents Chemother. 2017 11; 61(11). Chatterjee SS, Chen L, Gilbert A, da Costa TM, Nair V, Datta SK, Kreiswirth BN, Chambers HF. PMID: 28807923; PMCID: PMC5655059.
      View in: PubMed   Mentions: 18     Fields:    Translation:Cells
    56. Antimicrobial Stewardship Approaches in the Intensive Care Unit. Infect Dis Clin North Am. 2017 09; 31(3):513-534. Doernberg SB, Chambers HF. PMID: 28687210.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    57. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med. 2017 06 29; 376(26):2545-2555. Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF, DMID 07-0051 Team. PMID: 28657870; PMCID: PMC6886470.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    58. High-Level Resistance of Staphylococcus aureus to β-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4). Antimicrob Agents Chemother. 2017 06; 61(6). Hamilton SM, Alexander JAN, Choo EJ, Basuino L, da Costa TM, Severin A, Chung M, Aedo S, Strynadka NCJ, Tomasz A, Chatterjee SS, Chambers HF. PMID: 28373193; PMCID: PMC5444179.
      View in: PubMed   Mentions: 26     Fields:    Translation:Cells
    59. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? Antimicrob Agents Chemother. 2017 04; 61(4). Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, Hujer KM, Marshall EK, Rudin SD, Perez F, Wilson BM, Wasserman RB, Chikowski L, Paterson DL, Vila AJ, van Duin D, Kreiswirth BN, Chambers HF, Fowler VG, Jacobs MR, Pulse ME, Weiss WJ, Bonomo RA. PMID: 28167541; PMCID: PMC5365724.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansAnimalsCells
    60. The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress. Clin Infect Dis. 2017 Mar 15; 64(suppl_1):S3-S7. Chambers HF, Cross HR, Evans SR, Kreiswirth BN, Fowler VG, Antibacterial Resistance Leadership Group (ARLG). PMID: 28350896; PMCID: PMC5850447.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis. Antimicrob Agents Chemother. 2017 03; 61(3). Nigo M, Diaz L, Carvajal LP, Tran TT, Rios R, Panesso D, Garavito JD, Miller WR, Wanger A, Weinstock G, Munita JM, Arias CA, Chambers HF. PMID: 28232309; PMCID: PMC5328541.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    62. Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Infect Chemother. 2016 12; 48(4):267-273. Choo EJ, Chambers HF. PMID: 28032484; PMCID: PMC5204005.
      View in: PubMed   Mentions: 59  
    63. IVIG-mediated protection against necrotizing pneumonia caused by MRSA. Sci Transl Med. 2016 09 21; 8(357):357ra124. Diep BA, Le VT, Badiou C, Le HN, Pinheiro MG, Duong AH, Wang X, Dip EC, Aguiar-Alves F, Basuino L, Marbach H, Mai TT, Sarda MN, Kajikawa O, Matute-Bello G, Tkaczyk C, Rasigade JP, Sellman BR, Chambers HF, Lina G. PMID: 27655850.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    64. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 09; 60(9):5276-84. Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E, Chambers HF, Doernberg S. PMID: 27324762; PMCID: PMC4997864.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    65. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center. Antimicrob Agents Chemother. 2016 08; 60(8):4684-9. Pollett S, Baxi SM, Rutherford GW, Doernberg SB, Bacchetti P, Chambers HF. PMID: 27216053; PMCID: PMC4958157.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    66. Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis. Antimicrob Agents Chemother. 2016 07; 60(7):3976-9. Chambers HF, Basuino L, Hamilton SM, Choo EJ, Moise P. PMID: 27090173; PMCID: PMC4914634.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    67. PBP 4 Mediates High-Level Resistance to New-Generation Cephalosporins in Staphylococcus aureus. Antimicrob Agents Chemother. 2016 07; 60(7):3934-41. Chan LC, Gilbert A, Basuino L, da Costa TM, Hamilton SM, Dos Santos KR, Chambers HF, Chatterjee SS. PMID: 27067335; PMCID: PMC4914628.
      View in: PubMed   Mentions: 17     Fields:    Translation:Cells
    68. Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance. PLoS One. 2016; 11(2):e0149541. Greninger AL, Chatterjee SS, Chan LC, Hamilton SM, Chambers HF, Chiu CY. PMID: 26890675; PMCID: PMC4758708.
      View in: PubMed   Mentions: 30     Fields:    Translation:Cells
    69. Antibacterial Treatment for Uncomplicated Skin Infections. N Engl J Med. 2015 06 18; 372(25):2460. Miller LG, Daum RS, Chambers HF. PMID: 26083210.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    70. Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother. 2015; 59(6):3252-6. Chan LC, Basuino L, Dip EC, Chambers HF. PMID: 25801564; PMCID: PMC4432129.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    71. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015 Mar 19; 372(12):1093-103. Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, Pettibone S, Hoagland RJ, Chambers HF, DMID 07-0051 Team. PMID: 25785967; PMCID: PMC4547538.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    72. Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2015 May; 59(5):2960-3. Chan LC, Basuino L, Diep B, Hamilton S, Chatterjee SS, Chambers HF. PMID: 25753637; PMCID: PMC4394828.
      View in: PubMed   Mentions: 34     Fields:    Translation:Cells
    73. Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2014 Dec; 58(12):7617. Chambers HF. PMID: 25392536; PMCID: PMC4249517.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    74. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15; 59(2):e10-52. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC, Infectious Diseases Society of America. PMID: 24973422.
      View in: PubMed   Mentions: 510     Fields:    Translation:Humans
    75. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014 Jul 15; 59(2):147-59. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. PMID: 24947530.
      View in: PubMed   Mentions: 273     Fields:    Translation:Humans
    76. Pharmacology and the treatment of complicated skin and skin-structure infections. N Engl J Med. 2014 Jun 05; 370(23):2238-9. Chambers HF. PMID: 24897088.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    77. Global gene expression of methicillin-resistant Staphylococcus aureus USA300 during human and mouse infection. J Infect Dis. 2014 May 15; 209(10):1542-50. Date SV, Modrusan Z, Lawrence M, Morisaki JH, Toy K, Shah IM, Kim J, Park S, Xu M, Basuino L, Chan L, Zeitschel D, Chambers HF, Tan MW, Brown EJ, Diep BA, Hazenbos WL. PMID: 24286981.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    78. Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. J Infect Dis. 2013 Jul; 208(1):75-82. Diep BA, Afasizheva A, Le HN, Kajikawa O, Matute-Bello G, Tkaczyk C, Sellman B, Badiou C, Lina G, Chambers HF. PMID: 23532096; PMCID: PMC3666136.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    79. Epidemiologic Similarities in Pediatric Community-Associated Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus in the San Francisco Bay Area. J Pediatric Infect Dis Soc. 2012 Sep; 1(3):200-11. Hsiang MS, Shiau R, Nadle J, Chan L, Lee B, Chambers HF, Pan E. PMID: 23687577; PMCID: PMC3656541.
      View in: PubMed   Mentions: 9     Fields:    
    80. Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2012 Sep; 55(6):781-8. Tattevin P, Schwartz BS, Graber CJ, Volinski J, Bhukhen A, Bhukhen A, Mai TT, Vo NH, Dang DN, Phan TH, Basuino L, Perdreau-Remington F, Chambers HF, Diep BA. PMID: 22670044; PMCID: PMC3657511.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsPHPublic Health
    81. Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis. 2012 Sep; 55(5):615-20. Doernberg SB, Winston LG, Deck DH, Chambers HF. PMID: 22563022; PMCID: PMC3491851.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    82. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. PLoS Pathog. 2012 Feb; 8(2):e1002505. Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, Chambers HF, Tomasz A. PMID: 22319446; PMCID: PMC3271070.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    83. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011 Feb 01; 52(3):285-92. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. PMID: 21217178.
      View in: PubMed   Mentions: 554     Fields:    Translation:HumansCells
    84. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011 Feb 01; 52(3):e18-55. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF, Infectious Diseases Society of America. PMID: 21208910.
      View in: PubMed   Mentions: 957     Fields:    Translation:HumansCells
    85. A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes. Antimicrob Agents Chemother. 2010 Nov; 54(11):4900-2. Banerjee R, Gretes M, Harlem C, Basuino L, Chambers HF. PMID: 20805396; PMCID: PMC2976154.
      View in: PubMed   Mentions: 60     Fields:    Translation:Cells
    86. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A. 2010 Mar 23; 107(12):5587-92. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, Mai TT, Marbach H, Braughton KR, Whitney AR, Gardner DJ, Fan X, Tseng CW, Liu GY, Badiou C, Etienne J, Lina G, Matthay MA, DeLeo FR, Chambers HF. PMID: 20231457; PMCID: PMC2851770.
      View in: PubMed   Mentions: 187     Fields:    Translation:HumansAnimalsCells
    87. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010 May 01; 375(9725):1557-68. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. PMID: 20206987; PMCID: PMC3511788.
      View in: PubMed   Mentions: 565     Fields:    Translation:HumansCells
    88. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid. J Clin Microbiol. 2010 Feb; 48(2):568-74. Mendes RE, Sader HS, Deshpande LM, Diep BA, Chambers HF, Jones RN. PMID: 19940054; PMCID: PMC2815625.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsCTClinical Trials
    89. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2010 Feb; 54(2):610-3. Tattevin P, Basuino L, Bauer D, Diep BA, Chambers HF. PMID: 19917746; PMCID: PMC2812130.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    90. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009 Sep; 7(9):629-41. Chambers HF, Deleo FR. PMID: 19680247; PMCID: PMC2871281.
      View in: PubMed   Mentions: 967     Fields:    Translation:HumansCellsPHPublic Health
    91. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest. 2009 Sep; 119(9):2464-74. DeLeo FR, Chambers HF. PMID: 19729844; PMCID: PMC2735934.
      View in: PubMed   Mentions: 202     Fields:    Translation:HumansCellsPHPublic Health
    92. Coming home with MRSA. Arch Intern Med. 2009 Aug 10; 169(15):1379-80. Winston L, Chambers H. PMID: 19667300.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    93. Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300. Clin Infect Dis. 2009 May 15; 48(10):1483-4. Schwartz BS, Graber CJ, Diep BA, Basuino L, Perdreau-Remington F, Chambers HF. PMID: 19374563.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    94. Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Res Microbiol. 2009 Apr; 160(3):187-92. Tattevin P, Basuino L, Chambers HF. PMID: 19366630.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    95. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 2009 Apr 07; 106(14):5883-8. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y, Otto M. PMID: 19293374; PMCID: PMC2667066.
      View in: PubMed   Mentions: 224     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    96. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009 Mar 15; 48(6):713-21. Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW. PMID: 19207079.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    97. Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis. Antimicrob Agents Chemother. 2009 Apr; 53(4):1463-7. Chambers HF, Basuino L, Diep BA, Steenbergen J, Zhang S, Tattevin P, Alder J. PMID: 19171803; PMCID: PMC2663086.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    98. Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr. 2008 Oct 01; 49(2):231-3. Graber CJ, Jacobson MA, Perdreau-Remington F, Chambers HF, Diep BA. PMID: 18820536.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    99. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One. 2008 Sep 12; 3(9):e3198. Diep BA, Palazzolo-Ballance AM, Tattevin P, Basuino L, Braughton KR, Whitney AR, Chen L, Kreiswirth BN, Otto M, DeLeo FR, Chambers HF. PMID: 18787708; PMCID: PMC2527530.
      View in: PubMed   Mentions: 99     Fields:    Translation:AnimalsCells
    100. Clinical decisions. Management of skin and soft-tissue infection. N Engl J Med. 2008 Sep 04; 359(10):1063-7. Chambers HF, Moellering RC, Kamitsuka P. PMID: 18768953.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    101. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008 Jul 28; 168(14):1585-91. Hersh AL, Chambers HF, Maselli JH, Gonzales R. PMID: 18663172.
      View in: PubMed   Mentions: 192     Fields:    Translation:HumansPHPublic Health
    102. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2008 Jun 01; 197(11):1523-30. Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages SA, Jones A, Palazzolo-Ballance AM, Perdreau-Remington F, Sensabaugh GF, DeLeo FR, Chambers HF. PMID: 18700257.
      View in: PubMed   Mentions: 200     Fields:    Translation:AnimalsCells
    103. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008 Jun 01; 46 Suppl 5:S368-77. Stryjewski ME, Chambers HF. PMID: 18462092.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    104. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis. 2008 Jun 01; 46(11):1637-46. Liu C, Graber CJ, Karr M, Diep BA, Basuino L, Schwartz BS, Enright MC, O'Hanlon SJ, Thomas JC, Perdreau-Remington F, Gordon S, Gunthorpe H, Jacobs R, Jensen P, Leoung G, Rumack JS, Chambers HF. PMID: 18433335.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCellsPHPublic Health
    105. In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2008 Jun; 52(6):2089-96. Banerjee R, Gretes M, Basuino L, Strynadka N, Chambers HF. PMID: 18378703; PMCID: PMC2415812.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    106. Determining whether methicillin-resistant Staphylococcus aureus is associated with health care. JAMA. 2008 Feb 06; 299(5):519; author reply 519-20. David MZ, Siegel JD, Chambers HF, Daum RS. PMID: 18252879.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    107. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med. 2008 Feb 19; 148(4):249-57. Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL, Chen JH, Lin F, Lin J, Phan TH, Carleton HA, McDougal LK, Tenover FC, Cohen DE, Mayer KH, Sensabaugh GF, Perdreau-Remington F. PMID: 18283202.
      View in: PubMed   Mentions: 154     Fields:    Translation:HumansCells
    108. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007 Nov; 51(11):4044-8. Rajendran PM, Young D, Maurer T, Chambers H, Perdreau-Remington F, Ro P, Harris H. PMID: 17846141; PMCID: PMC2151464.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    109. Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin? Expert Rev Anti Infect Ther. 2007 Jun; 5(3):333-5. Chambers HF, Hegde SS. PMID: 17547497.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    110. Mechanism of cell surface expression of the Streptococcus mitis platelet binding proteins PblA and PblB. Mol Microbiol. 2007 May; 64(3):844-57. Mitchell J, Siboo IR, Takamatsu D, Chambers HF, Sullam PM. PMID: 17462028.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    111. Intermediate vancomycin susceptibility in a community-associated MRSA clone. Emerg Infect Dis. 2007 Mar; 13(3):491-3. Graber CJ, Wong MK, Carleton HA, Perdreau-Remington F, Haller BL, Chambers HF. PMID: 17552110; PMCID: PMC2725904.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    112. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006 Aug 17; 355(7):653-65. Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S. aureus Endocarditis and Bacteremia Study Group. PMID: 16914701.
      View in: PubMed   Mentions: 423     Fields:    Translation:HumansCells
    113. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology. 2006 Aug; 113(8):1455-62. Rutar T, Chambers HF, Crawford JB, Perdreau-Remington F, Zwick OM, Karr M, Diehn JJ, Cockerham KP. PMID: 16766029.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    114. Diabetic ketoacidosis precipitated by Staphylococcus aureus abscess and bacteremia due to acupuncture: case report and review of the literature. Clin Infect Dis. 2006 Jul 01; 43(1):e6-8. Seeley EJ, Chambers HF. PMID: 16758409.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    115. Ceftobiprole: in-vivo profile of a bactericidal cephalosporin. Clin Microbiol Infect. 2006 Apr; 12 Suppl 2:17-22. Chambers HF. PMID: 16524424.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    116. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005 Nov 15; 41(10):1373-406. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC, Infectious Diseases Society of America. PMID: 16231249.
      View in: PubMed   Mentions: 348     Fields:    Translation:HumansAnimals
    117. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 2005 Aug; 49(8):3163-5. Madrigal AG, Basuino L, Chambers HF. PMID: 16048918; PMCID: PMC1196289.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    118. Imipenem for treatment of tuberculosis in mice and humans. Antimicrob Agents Chemother. 2005 Jul; 49(7):2816-21. Chambers HF, Turner J, Schecter GF, Kawamura M, Hopewell PC. PMID: 15980354; PMCID: PMC1168716.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    119. Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area. Clin Infect Dis. 2005 Jun 01; 40(11):1617-24. Eguia JM, Liu C, Moore M, Wrone EM, Pont J, Gerberding JL, Chambers HF. PMID: 15889359.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    120. Community-associated MRSA--resistance and virulence converge. N Engl J Med. 2005 Apr 07; 352(14):1485-7. Chambers HF. PMID: 15814886.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCellsPHPublic Health
    121. Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infect Immun. 2005 Apr; 73(4):2273-80. Siboo IR, Chambers HF, Sullam PM. PMID: 15784571; PMCID: PMC1087419.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansAnimalsCells
    122. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 2005 Mar; 49(3):884-8. Chambers HF. PMID: 15728879; PMCID: PMC549268.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    123. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004 Sep; 139(9):947-51; discussion 951-3. Young DM, Harris HW, Charlebois ED, Chambers H, Campbell A, Perdreau-Remington F, Lee C, Mankani M, Mackersie R, Schecter WP. PMID: 15381611.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCellsPHPublic Health
    124. Crystal structures of the Apo and penicillin-acylated forms of the BlaR1 beta-lactam sensor of Staphylococcus aureus. J Biol Chem. 2004 Nov 05; 279(45):47278-87. Wilke MS, Hills TL, Zhang HZ, Chambers HF, Strynadka NC. PMID: 15322076.
      View in: PubMed   Mentions: 28     Fields:    Translation:Cells
    125. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2004 Jul 01; 39(1):47-54. Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, Ng VL, Chansky K, Edlin BR, Edlin B, Chambers HF. PMID: 15206052; PMCID: PMC2567833.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    126. API 20 strep identification system may incorrectly speciate enterococci with low level resistance to vancomycin. Diagn Microbiol Infect Dis. 2004 Apr; 48(4):287-8. Winston LG, Pang S, Haller BL, Wong M, Chambers HF, Perdreau-Remington F. PMID: 15062923.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    127. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis. 2004 Apr 01; 38(7):994-1000. Carpenter CF, Chambers HF. PMID: 15034832.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCells
    128. PBP 2a mutations producing very-high-level resistance to beta-lactams. Antimicrob Agents Chemother. 2004 Feb; 48(2):453-9. Katayama Y, Zhang HZ, Chambers HF. PMID: 14742194; PMCID: PMC321522.
      View in: PubMed   Mentions: 26     Fields:    Translation:Cells
    129. Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors. Curr Infect Dis Rep. 2003 Dec; 5(6):459-466. Eguia JM, Chambers HF. PMID: 14642185.
      View in: PubMed   Mentions: 8  
    130. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother. 2003 Oct; 47(10):3040-5. Liu C, Chambers HF. PMID: 14506006; PMCID: PMC201119.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCells
    131. Jumping the barrier to beta-lactam resistance in Staphylococcus aureus. J Bacteriol. 2003 Sep; 185(18):5465-72. Katayama Y, Zhang HZ, Hong D, Chambers HF. PMID: 12949098; PMCID: PMC193760.
      View in: PubMed   Mentions: 41     Fields:    Translation:Cells
    132. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother. 2003 Apr; 47(4):1262-6. Moore MR, Perdreau-Remington F, Chambers HF. PMID: 12654656; PMCID: PMC152514.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimals
    133. Solving staphylococcal resistance to beta-lactams. Trends Microbiol. 2003 Apr; 11(4):145-8. Chambers HF. PMID: 12706985.
      View in: PubMed   Mentions: 10     Fields:    Translation:Cells
    134. Methicillin-resistant staphylococci and their treatment in the intensive care unit. Semin Respir Crit Care Med. 2003 Feb; 24(1):37-48. Eguia JM, Chambers HF. PMID: 16088523.
      View in: PubMed   Mentions: 1     Fields:    
    135. Effect of disruption of Staphylococcus aureus PBP4 gene on resistance to beta-lactam antibiotics. Microb Drug Resist. 2003; 9(4):329-36. Katayama Y, Zhang HZ, Chambers HF. PMID: 15000739.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    136. Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital. Am J Infect Control. 2002 Nov; 30(7):400-6. Winston LG, Bangsberg DR, Chambers HF, Felt SC, Rosen JI, Charlebois ED, Wong M, Steele L, Gerberding JL, Perdreau-Remington F. PMID: 12410216.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    137. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis. 2002 Feb 15; 34(4):425-33. Charlebois ED, Bangsberg DR, Moss NJ, Moore MR, Moss AR, Chambers HF, Perdreau-Remington F. PMID: 11797167.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    138. Identifying pulmonary tuberculosis in patients with negative sputum smear results. Chest. 2001 Aug; 120(2):349-55. Kanaya AM, Glidden DV, Chambers HF. PMID: 11502628.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    139. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001 Mar-Apr; 7(2):178-82. Chambers HF. PMID: 11294701; PMCID: PMC2631711.
      View in: PubMed   Mentions: 378     Fields:    Translation:HumansCells
    140. Methicillin-resistant Staphylococcus aureus. Mechanisms of resistance and implications for treatment. Postgrad Med. 2001 Feb; 109(2 Suppl):43-50. Chambers HF. PMID: 19667557.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    141. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Antimicrob Agents Chemother. 1999 Nov; 43(11):2742-6. Chambers HF, Xiang Q, Chow LL, Hackbarth C. PMID: 10543757; PMCID: PMC89553.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    142. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. J Infect Dis. 1999 Sep; 180(3):896-9. Martin JN, Perdreau-Remington F, Kartalija M, Pasi OG, Webb M, Gerberding JL, Chambers HF, Täuber MG, Lee BL. PMID: 10438389.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    143. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1998 Dec; 42(12):3325-7. Kim YS, Liu Q, Chow LL, Chambers HF, Täuber MG. PMID: 9835540; PMCID: PMC106048.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    144. Suppurative parotitis. West J Med. 1998 Aug; 169(2):116-7. Sheppard DC, Chambers HF. PMID: 9735697; PMCID: PMC1305186.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    145. Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin Infect Dis. 1998 Apr; 26(4):874-7. Chambers HF, Kocagöz T, Sipit T, Turner J, Hopewell PC. PMID: 9564467.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCellsCTClinical Trials
    146. Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother. 1997 May; 41(5):1182-5. Hackbarth CJ, Unsal I, Chambers HF. PMID: 9145897; PMCID: PMC163878.
      View in: PubMed   Mentions: 24     Fields:    Translation:Cells
    147. Burden of Mycobacterium tuberculosis in sputum samples can be reliably determined using a quantitative, non-radioactive polymerase chain reaction assay. Tuber Lung Dis. 1996 Dec; 77(6):496-501. Sweet-Cordero EA, Chambers HF, Cicero-Sabido R, Santos-Preciado JI. PMID: 9039441.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    148. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother. 1996 Aug; 40(8):1768-74. Kocagöz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. PMID: 8843279; PMCID: PMC163415.
      View in: PubMed   Mentions: 45     Fields:    Translation:Cells
    149. Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit model. Antimicrob Agents Chemother. 1996 May; 40(5):1308-10. Frank U, Chambers HF. PMID: 8723492; PMCID: PMC163317.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    150. Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine. Clin Pharmacol Ther. 1996 Jan; 59(1):14-21. Lee BL, Täuber MG, Sadler B, Goldstein D, Chambers HF. PMID: 8549029.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    151. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Antimicrob Agents Chemother. 1995 Dec; 39(12):2620-4. Chambers HF, Moreau D, Yajko D, Miick C, Wagner C, Hackbarth C, Kocagöz S, Rosenberg E, Hadley WK, Nikaido H. PMID: 8592990; PMCID: PMC163000.
      View in: PubMed   Mentions: 69     Fields:    Translation:AnimalsCells
    152. Quantitative culture of Mycobacterium tuberculosis from clinical sputum specimens and dilution endpoint of its detection by the Amplicor PCR assay. J Clin Microbiol. 1995 Jul; 33(7):1944-7. Yajko DM, Wagner C, Tevere VJ, Kocagöz T, Hadley WK, Chambers HF. PMID: 7665679; PMCID: PMC228308.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    153. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J Infect Dis. 1995 Apr; 171(4):897-902. Chambers HF, Kartalija M, Sande M. PMID: 7706817.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    154. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a. Antimicrob Agents Chemother. 1995 Feb; 39(2):462-6. Chambers HF. PMID: 7726516; PMCID: PMC162561.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    155. Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance. Antimicrob Agents Chemother. 1995 Jan; 39(1):103-6. Hackbarth CJ, Kocagoz T, Kocagoz S, Chambers HF. PMID: 7695289; PMCID: PMC162493.
      View in: PubMed   Mentions: 29     Fields:    Translation:Cells
    156. Altered production of penicillin-binding protein 2a can affect phenotypic expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1994 Nov; 38(11):2568-71. Hackbarth CJ, Miick C, Chambers HF. PMID: 7872749; PMCID: PMC188243.
      View in: PubMed   Mentions: 14     Fields:    Translation:Cells
    157. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits. J Antimicrob Chemother. 1993 Sep; 32(3):453-8. Chambers HF, Fournier MA. PMID: 8262867.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    158. Detection of methicillin-resistant staphylococci. Infect Dis Clin North Am. 1993 Jun; 7(2):425-33. Chambers HF. PMID: 8345177.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    159. blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1993 May; 37(5):1144-9. Hackbarth CJ, Chambers HF. PMID: 8517704; PMCID: PMC187918.
      View in: PubMed   Mentions: 62     Fields:    Translation:Cells
    160. Short-course combination and oral therapies of Staphylococcus aureus endocarditis. Infect Dis Clin North Am. 1993 Mar; 7(1):69-80. Chambers HF. PMID: 8463654.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    161. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1992 Jul; 30 Suppl A:117-22. Chambers HF. PMID: 1399943.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    162. Characterization of penicillin-binding protein 2 of Staphylococcus aureus: deacylation reaction and identification of two penicillin-binding peptides. Antimicrob Agents Chemother. 1992 Mar; 36(3):656-61. Chambers HF, Miick C. PMID: 1622180; PMCID: PMC190574.
      View in: PubMed   Mentions: 14     Fields:    Translation:Cells
    163. Effect of protein binding of daptomycin on MIC and antibacterial activity. Antimicrob Agents Chemother. 1991 Dec; 35(12):2505-8. Lee BL, Sachdeva M, Chambers HF. PMID: 1667253; PMCID: PMC245421.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    164. Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1991 Dec; 35(12):2574-9. Gerberding JL, Miick C, Liu HH, Chambers HF. PMID: 1810191; PMCID: PMC245433.
      View in: PubMed   Mentions: 37     Fields:    Translation:AnimalsCells
    165. Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of beta-lactamase. Antimicrob Agents Chemother. 1991 Oct; 35(10):1975-9. Barg N, Chambers H, Kernodle D. PMID: 1759816; PMCID: PMC245310.
      View in: PubMed   Mentions: 18     Fields:    Translation:Cells
    166. Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 1991 Jan; 12(1):29-35. Chambers HF. PMID: 1847961.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    167. Characterization of mechanisms of resistance to beta-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus. Antimicrob Agents Chemother. 1990 Sep; 34(9):1780-2. Stratton CW, Gelfand MS, Gerberding JL, Chambers HF. PMID: 2285290; PMCID: PMC171924.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    168. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus. J Infect Dis. 1990 Sep; 162(3):705-10. Chambers HF, Sachdeva M, Kennedy S. PMID: 2387996.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    169. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother. 1990 Jun; 34(6):1227-31. Small PM, Chambers HF. PMID: 2393284; PMCID: PMC171789.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    170. Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. J Infect Dis. 1990 Jun; 161(6):1170-6. Chambers HF, Sachdeva M. PMID: 2345297.
      View in: PubMed   Mentions: 55     Fields:    Translation:Cells
    171. Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrob Agents Chemother. 1990 Apr; 34(4):510-4. Chambers HF, Kennedy S. PMID: 2140496; PMCID: PMC171634.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    172. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet. 1989 Nov 04; 2(8671):1071-3. Dworkin RJ, Lee BL, Sande MA, Chambers HF. PMID: 2572799.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    173. Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits. Antimicrob Agents Chemother. 1989 Oct; 33(10):1822-3. Padula A, Chambers HF. PMID: 2686548; PMCID: PMC172764.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    174. Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits. Antimicrob Agents Chemother. 1989 Sep; 33(9):1522-5. Kennedy S, Chambers HF. PMID: 2554799; PMCID: PMC172694.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    175. Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob Agents Chemother. 1989 Jul; 33(7):991-4. Hackbarth CJ, Chambers HF. PMID: 2675759; PMCID: PMC176050.
      View in: PubMed   Mentions: 36     Fields:    Translation:Cells
    176. Methicillin-resistant staphylococci: detection methods and treatment of infections. Antimicrob Agents Chemother. 1989 Jul; 33(7):995-9. Hackbarth CJ, Chambers HF. PMID: 2675760; PMCID: PMC176051.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    177. Low-level methicillin resistance in strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1989 Apr; 33(4):424-8. Chambers HF, Archer G, Matsuhashi M. PMID: 2729937; PMCID: PMC172453.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    178. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988 Oct 15; 109(8):619-24. Chambers HF, Miller RT, Newman MD. PMID: 3421575.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    179. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med. 1988 Aug; 85(2):172-6. Jacobson MA, Gellermann H, Chambers H. PMID: 3400693.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    180. Methicillin-resistant staphylococci. Clin Microbiol Rev. 1988 Apr; 1(2):173-86. Chambers HF. PMID: 3069195; PMCID: PMC358041.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    181. Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a. Antimicrob Agents Chemother. 1987 Dec; 31(12):1919-24. Chambers HF. PMID: 3439802; PMCID: PMC175828.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCells
    182. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1987 Dec; 31(12):1982-8. Chambers HF, Hackbarth CJ. PMID: 3439805; PMCID: PMC175839.
      View in: PubMed   Mentions: 49     Fields:    Translation:Cells
    183. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci. Antimicrob Agents Chemother. 1987 Oct; 31(10):1549-52. Sachdeva M, Hackbarth C, Stella FB, Chambers HF. PMID: 3481245; PMCID: PMC174987.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    184. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J Infect Dis. 1987 Mar; 155(3):581-5. Chambers HF, Miller MH. PMID: 3643249.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    185. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1986 Sep; 30(3):382-4. Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA. PMID: 3640590; PMCID: PMC180564.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    186. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother. 1986 Apr; 29(4):611-3. Hackbarth CJ, Chambers HF, Sande MA. PMID: 3707110; PMCID: PMC180452.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    187. Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin. J Clin Invest. 1985 Jul; 76(1):325-31. Chambers HF, Hartman BJ, Tomasz A. PMID: 4019783; PMCID: PMC423778.
      View in: PubMed   Mentions: 58     Fields:    Translation:Cells
    188. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1985 May; 27(5):685-7. Sullam PM, Täuber MG, Hackbarth CJ, Chambers HF, Scott KG, Sande MA. PMID: 3860185; PMCID: PMC180132.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    189. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis. 1984 Nov-Dec; 6 Suppl 4:S870-4. Chambers HF, Mills J, Drake TA, Sande MA. PMID: 6522927.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    190. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1984 Jul; 26(1):61-4. Chambers HF, Sande MA. PMID: 6236747; PMCID: PMC179917.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    191. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. J Infect Dis. 1984 Jun; 149(6):894-903. Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA. PMID: 6564133.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    192. Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore). 1983 May; 62(3):170-7. Chambers HF, Korzeniowski OM, Sande MA. PMID: 6843356.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Henry's Networks
    Concepts (529)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (61)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.